Colonic Cytokinetics and Cell Signaling: Dietary Effects
Colonic Cytokinetics and Cell Signaling: Dietary Effects
批准号:
7224941
负责人:
Robert Stephen Chapkin
金额:
$25.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-12-23 至 2008-04-30
关键词:
AddressApoptosisApoptoticArachidonic AcidsAzoxymethaneBindingBoxingButyratesCarcinogen exposureCarcinomaCell DeathCell Death Signaling ProcessCell LineCell membraneCellsClassClinicalColonColon CarcinomaColonic NeoplasmsColorectal AdenomaColorectal NeoplasmsDNA AdductsDataDevelopmentDietDietary FactorsDietary FatsDocosahexaenoic AcidsEicosapentaenoic AcidEnvironmentEpigenetic ProcessEpithelial CellsEquilibriumExperimental ModelsFatty AcidsFunctional disorderFundingGenus ColaGoalsGrowthGuanine NucleotidesGuidelinesHealth Care CostsHumanIn VitroIncidenceInhibition of ApoptosisLeadLinoleic AcidsMalignant - descriptorMediatingMembraneMitochondriaMolecularMusNumbersObject AttachmentOmega-3 Fatty AcidsOncogenicOxidative StressPathway interactionsPhasePhospholipidsPolyunsaturated Fatty AcidsPositioning AttributeProgress ReportsPropertyQuality of lifeRattusRelative (related person)SOD2 geneSignal PathwaySignal TransductionStressTestingTherapeuticThinkingTimeTumor Necrosis Factor Ligand Superfamily Member 6Tumor PromotionUnited States Environmental Protection AgencyUp-Regulationbasebutyratecancer preventionfeedingimprovedin vivolipid Imitochondrial membraneoxidationprotective effectresearch studytraffickingtumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Among dietary factors, there are cogent data indicating a protective effect of n-3 polyunsaturated fatty acids (PUFA) e.g., eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), on colon cancer. In contrast, dietary lipids rich in n-6 PUFA, e.g., linoleic acid (18:2n-6) and arachidonic acid (20:4n-6), enhance the development of colon tumors. This is significant because the typical Western diet contains 10 to 20 times more n-6 than n-3 PUFA. Unfortunately, to date, a unifying mechanistic hypothesis addressing why n-3 PUFA selectively suppress colon cancer compared to n-6 PUFA (the major dietary form of PUFA in the U.S. diet) is lacking. We have recently shown that (i) the antitumorigenic effects of n-3 PUFA are in part the result of the coordinated upregulation of targeted apoptosis dudng the initiation phase of tumorigenesis and spontaneous apoptosis during tumor promotion; (ii) the effect is enhanced by butyrate; (iii) EPA and DHA induce compositional changes in mitochonddal membrane phospholipids which facilitate apoptosis; and (iv) n-3 PUFA suppress oncogenic Ras activation, a powerful antiapoptotic signal in the colon. Since the inhibition of apoptosis is now thought to be an integral component in the genesis of colorectal tumors, the overall goal of this proposal is to understand how n-3 PUFA promote apoptosis in colonocytes. Since n-3 PUFA are uniquely capable of altering cell membrane properties due to both the number and position of double bonds, we have hypothesized that n-3 PUFA alter colonocyte mitochondrial and plasma membrane composition and function, thereby creating a permissive environment for apoptosis. We propose to utilize a combination of experimental models (azoxymethane-injected rat, oxidatively stressed SOD2+/- mouse; normal and malignant transformed mouse and human colonocyte cell lines) in order to elucidate n-3 PUFA apoptogenic signaling in the colon. To test our hypothesis the following specific aims are proposed: Aim #1 will elucidate the mechanisms by which n-3 PUFA modulate intrinsic (mitochondria-mediated) cell death signaling; and Aim #2 will determine the mechanisms by which n-3 PUFA modulate extrinsic (non-mitochondrial) cell death signaling. At present, the molecular basis of the n-3 PUFA effects on colonocyte apoptosis is a complete black box. The proposed experiments represent the first attempt to provide an explanation of EPA and DHA action at the molecular level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
-
批准号:10717469
-
项目类别:
-
资助金额:$72.25万
-
财政年份:2023
-
负责人:Robert Stephen Chapkin
-
依托单位:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
-
批准号:10047029
-
项目类别:
-
资助金额:$57.92万
-
财政年份:2020
-
负责人:Robert Stephen Chapkin
-
依托单位:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
-
批准号:10401939
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2020
-
负责人:Robert Stephen Chapkin
-
依托单位:
Diet and the colonic exfoliome: a novel, non-invasive approach to testing interventions in humans
-
批准号:10603601
-
项目类别:
-
资助金额:$19.05万
-
财政年份:2020
-
负责人:Robert Stephen Chapkin
-
依托单位:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
-
批准号:10630909
-
项目类别:
-
资助金额:$53.69万
-
财政年份:2020
-
负责人:Robert Stephen Chapkin
-
依托单位:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
-
批准号:10252842
-
项目类别:
-
资助金额:$55.28万
-
财政年份:2020
-
负责人:Robert Stephen Chapkin
-
依托单位:
Dietary Flavonoids-Microbiota-Ah Receptor Interactions in the Gut
-
批准号:9791345
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2018
-
负责人:Robert Stephen Chapkin
-
依托单位:
Dietary Flavonoids-Microbiota-Ah Receptor Interactions in the Gut
-
批准号:10247052
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2018
-
负责人:Robert Stephen Chapkin
-
依托单位:
Dietary and microbial predictors of childhood obesity risk
-
批准号:9892995
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2017
-
负责人:Robert Stephen Chapkin
-
依托单位:
Role of Aryl Hydrocarbon Receptor in Microbiota-Colon Stem Cell Interactions
-
批准号:9102325
-
项目类别:
-
资助金额:$39.59万
-
财政年份:2016
-
负责人:Robert Stephen Chapkin
-
依托单位:
Molecular basis for dietary chemoprevention
-
批准号:10348744
-
项目类别:
-
资助金额:$80.62万
-
财政年份:2016
-
负责人:Robert Stephen Chapkin
-
依托单位:
Chemoprotective effects of natural products on colonic adult stem cells
-
批准号:9126694
-
项目类别:
-
资助金额:$9.68万
-
财政年份:2015
-
负责人:Robert Stephen Chapkin
-
依托单位:
Chemoprotective effects of natural products on colonic adult stem cells
-
批准号:8330239
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
Gut Microbiota and colonic gene expression: A ligran trial in humans
-
批准号:8330754
-
项目类别:
-
资助金额:$66.98万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
Chemoprotective effects of natural products on colonic adult stem cells
-
批准号:8704733
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
Chemoprotective effects of natural products on colonic adult stem cells
-
批准号:8902055
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
Chemoprotective effects of natural products on colonic adult stem cells
-
批准号:8513281
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
Gut Microbiota and colonic gene expression: A ligran trial in humans
-
批准号:8548301
-
项目类别:
-
资助金额:$61.71万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
Chemoprotective effects of natural products on colonic adult stem cells
-
批准号:8196591
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
Gut Microbiota and colonic gene expression: A ligran trial in humans
-
批准号:8726945
-
项目类别:
-
资助金额:$60.79万
-
财政年份:2011
-
负责人:Robert Stephen Chapkin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: